1. Home
  2. DYN vs LRN Comparison

DYN vs LRN Comparison

Compare DYN & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • LRN
  • Stock Information
  • Founded
  • DYN 1984
  • LRN 2000
  • Country
  • DYN United States
  • LRN United States
  • Employees
  • DYN N/A
  • LRN N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • LRN Other Consumer Services
  • Sector
  • DYN Health Care
  • LRN Real Estate
  • Exchange
  • DYN Nasdaq
  • LRN Nasdaq
  • Market Cap
  • DYN 3.4B
  • LRN 3.5B
  • IPO Year
  • DYN 2020
  • LRN 2007
  • Fundamental
  • Price
  • DYN $28.39
  • LRN $100.54
  • Analyst Decision
  • DYN Strong Buy
  • LRN Buy
  • Analyst Count
  • DYN 9
  • LRN 5
  • Target Price
  • DYN $52.44
  • LRN $89.40
  • AVG Volume (30 Days)
  • DYN 1.0M
  • LRN 1.6M
  • Earning Date
  • DYN 11-12-2024
  • LRN 10-22-2024
  • Dividend Yield
  • DYN N/A
  • LRN N/A
  • EPS Growth
  • DYN N/A
  • LRN 53.12
  • EPS
  • DYN N/A
  • LRN 5.50
  • Revenue
  • DYN N/A
  • LRN $2,110,972,000.00
  • Revenue This Year
  • DYN N/A
  • LRN $13.18
  • Revenue Next Year
  • DYN N/A
  • LRN $8.32
  • P/E Ratio
  • DYN N/A
  • LRN $18.23
  • Revenue Growth
  • DYN N/A
  • LRN 11.55
  • 52 Week Low
  • DYN $9.82
  • LRN $54.81
  • 52 Week High
  • DYN $47.45
  • LRN $103.98
  • Technical
  • Relative Strength Index (RSI)
  • DYN 42.04
  • LRN 67.80
  • Support Level
  • DYN $27.99
  • LRN $99.15
  • Resistance Level
  • DYN $35.68
  • LRN $103.98
  • Average True Range (ATR)
  • DYN 2.09
  • LRN 2.55
  • MACD
  • DYN 0.23
  • LRN 0.40
  • Stochastic Oscillator
  • DYN 9.12
  • LRN 70.48

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional, and Private Pay Schools and Other.

Share on Social Networks: